Find Resources
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This study from the American Journal of Managed Care identifies the main factors influencing the implementation and sustainability of cross-sector data sharing between a community-based organization and an academic medical center via a case study of the Mid-Ohio Farmacy (MOF) produce referral program. The MOF is a unique program developed by the Mid-Ohio Food Collective and Ohio State University Wexner Medical Center (OSUWMC) to provide food insecure patients who have a qualifying chronic condition with money to purchase produce from food pantries on a monthly basis. Researchers conducted a series of key informant interviews with OSUWMC and Mid-Ohio Food Collective representatives to characterize the challenges of data sharing between the academic medical center and the community-based organization. Challenges were grouped into three main buckets: data sharing regulations, data exchange capabilities, and cross sector data integration. Some keys findings from this paper include the need for clarification around HIPPA regulations for data exchange between covered and non-covered entities, the importance of incorporating social-risk data (such as a food security screening tool) into the electronic health record, and the need for additional research and guidance around how to create fully integrated shared databases between health care and social service agencies.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
The article highlights the lessons learned from the COVID-19 pandemic and their influence on preparations for future public health emergencies. While the federal Public Health Emergency for COVID-19 is set to end in May 2023, the FDA emphasizes the continued importance of COVID-19 vaccines and treatments. Addressing misinformation and strengthening supply chain resilience are key priorities, and the FDA is developing more efficient inspection planning systems. Modernizing FDA authorities and maintaining a commitment to planning for the future are also emphasized to enhance national security and public health preparedness.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This study investigates deaf American Sign Language (ASL) users’ access to telehealth and outpatient encounters during the pandemic. The findings emphasize the importance of optimizing proactive accommodation planning and access including in telehealth platforms.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This article discusses strategies to promote equity in COVID-19 antiviral treatment. It highlights the disproportionate effect of the pandemic on marginalized groups and the need to address inequities in access to antiviral medications. The authors discuss barriers to equity, such as low awareness, limited access to healthcare, scarcity of therapeutics, and treatment prioritization. They propose strategies to overcome these barriers, including community-driven outreach campaigns, addressing healthcare costs for uninsured patients, transparent allocation of therapeutics, and monitoring data to ensure equity. The article emphasizes the importance of proactive and transparent approaches to promote health equity in COVID-19 treatment.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
This article discusses the Foundation for Opioid Response Efforts (FORE) distribution of $1.3 million in grants to organizations studying the potential permanent adoption of COVID-19 care access measures to promote health equity in opioid use disorder treatment. The grants aim to investigate the impact of temporary policies, such as virtual care, on access to care and patient outcomes. The studies will explore how relaxed prescribing policies for buprenorphine, telehealth strategies, and other COVID-19 measures have affected patient access and outcomes, particularly among underserved populations. The research will inform evidence-based policies to sustain access to better care beyond the pandemic and address the ongoing opioid crisis.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Systematic Review/Meta-Analysis
This review of state data collection and reporting practices during the COVID-19 pandemic found inconsistencies and gaps in data collected by race and ethnicity. Improved standardization across the U.S.–which may come in the form of a federally-operated centralized database–would address some of the concerns in data representation of all Americans.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Systematic Review/Meta-Analysis
This article is an overall summary of long COVID, its risk factors, and ways to address it. Many of the risk factors identified are clinical, yet some management options include self-treatment.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
White Paper/Brief
This article discusses the development of the Visible app, which uses wearables or smart watches to help measure and manage long COVID. Visible helps to manage long COVID and other chronic fatigue diseases with a heartrate-monitored guidance strategy that emphasizes pacing as long COVID patients return to physical activity.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study, Systematic Review/Meta-Analysis
This literature review outlines support for mobile health clinics as a successful and cost-effective method of healthcare delivery, especially towards underserved populations. Although financial and logistical challenges exist when implementing mobile health clinics, they ultimately help eliminate common barriers to health access. “Serving as a stepping-stone between the clinic and the community, MHCs are able to address both medical and social determinants of health, and have the potential to play an important role in our evolving healthcare system.”
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Systematic Review/Meta-Analysis
Structural inequality during the pandemic has likely compounded health care access barriers for low-income individuals and people of color, who face not only disproportionate health risks, but also greater difficulty in transportation access and heightened economic hardship due to COVID-19. Partnerships between health and transportation systems hold promise for jointly addressing disparities in health- and transportation-related challenges, but are largely limited to Medicaid-enrolled patients. Findings of this study suggest that transportation and health care providers should look for additional strategies to ensure that transportation access is not a reason for delayed medical care during and after the COVID-19 pandemic. Transportation stakeholders need to collaborate to increase access to transportation services. This paper focused on specific health care needs including dialysis, prenatal care, cancer treatment, mental-health and substance use treatment, and health care for people with disabilities.